Metabolomics Creative Proteomics
Submit Your Inquiry

Nicotinate and Nicotinamide LC–MS/MS Analysis Service

When NAD metabolism is central to your study, precursors like nicotinate and nicotinamide quickly become the bottleneck. Simple vitamin assays are not enough to explain redox shifts, pathway flux, or cofactor demand across conditions.

Our targeted nicotinate and nicotinamide LC–MS/MS panel quantifies key precursors and NAD intermediates across biofluids, tissues, and cells, with QC-anchored data packages that are ready for internal review and downstream modeling.

This service helps you:

  • Quantify NAD precursors with confidence: Targeted LC–MS/MS for nicotinate, nicotinamide, NAD⁺, NADP⁺, and related metabolites in one coherent panel.
  • See pathway bottlenecks, not just single values: Use precursor/intermediate ratios to distinguish de novo synthesis, salvage activity, and increased NAD consumption.
  • Work with real-world samples and limited volume: Optimized extraction and high-linearity calibration (R² typically ≥ 0.99) support small, precious research samples.
  • Scale to broader cofactor and vitamin networks: Seamlessly extend to one-carbon, CoA, or vitamin panels when your project moves beyond the NAD pathway.
CONTACT EXPERT
  • Service Details
  • FAQ
  • Publications
  • Submit Your Inquiry

Why Analyze Nicotinate and Nicotinamide?

Nicotinate and nicotinamide are central building blocks for the nicotinamide adenine dinucleotide pool. Through de novo synthesis from tryptophan and salvage pathways that recycle nicotinamide and nicotinamide riboside, cells maintain NAD and NADP levels to support glycolysis, the TCA cycle, oxidative phosphorylation, fatty acid oxidation, and many other redox-dependent reactions.

When precursor levels are perturbed, you may see:

  • Imbalanced NAD⁺/NADH or NADP⁺/NADPH ratios.
  • Compensatory changes in de novo versus salvage pathways.
  • Accumulation of downstream catabolites such as trigonelline or nicotinurate.

By profiling nicotinate, nicotinamide, and their derivatives alongside broader metabolomics data, you can:

  • Clarify whether changes in NAD metabolism are driven by precursor limitation, pathway bottlenecks, or increased consumption.
  • Link redox changes to nutrient status, cofactor metabolism, and one-carbon pathways.
  • Support mechanism-of-action studies for compounds that modulate NAD biosynthesis or salvage.

What Our Nicotinate and Nicotinamide Analysis Service Includes

Our nicotinate and nicotinamide analysis is built as a targeted metabolomics panel that can stand alone or be integrated into wider cofactor and vitamin profiling.

Typical service modules include:

  • Absolute quantification of nicotinate and nicotinamide in biofluids, tissues, cells, and other research samples.
  • Extended panel of related metabolites, including key intermediates and catabolites for pathway interpretation.
  • Custom panel design to add or remove analytes that are relevant to your model or intervention.
  • Optional integration with NAD species (NAD⁺, NADH, NADP⁺, NADPH) and one-carbon metabolites via linked services.
  • Data analysis and visualization, including group comparisons, ratios (for example nicotinate/nicotinamide), and basic pathway mapping.

Targeted Metabolite Panel: Nicotinate and Nicotinamide Pathway

Metabolite Name Abbreviation Biological Role / Pathway Node Sample Compatibility
Nicotinate NA Precursor in Preiss–Handler pathway Plasma, tissue, urine
Nicotinamide NAM Salvage pathway substrate Plasma, serum, urine, cells
NAD⁺ NAD⁺ Central redox cofactor in catabolic metabolism Tissue, cells, plasma
NADP⁺ NADP⁺ Redox cofactor for biosynthetic and antioxidant processes Cells, tissues
Nicotinamide mononucleotide NMN Intermediate in NAD⁺ salvage synthesis Plasma, liver, cultured cells
Nicotinate mononucleotide NaMN Intermediate from nicotinate to NAD⁺ Cells, tissues
Nicotinamide riboside NR Alternative precursor for NAD⁺ formation Plasma, supplements
Trigonelline Methylated nicotinate derivative; dietary exposure marker Urine, plasma
Nicotinurate Degradation product of nicotinate Urine
N-methyl-nicotinamide MNA Nicotinamide degradation product Urine, plasma

Advantages of Our Nicotinate and Nicotinamide Analysis Service

  • Sensitive LC–MS/MS quantification: Targeted methods capture low-abundance nicotinate/nicotinamide in small-volume samples.
  • High calibration linearity: Calibration curves are tuned for strong linearity, typically with R² ≥ 0.99 across working ranges.
  • QC-anchored reproducibility: Isotope-labeled internal standards and pooled QCs help keep batch-to-batch drift under tight control.
  • Easy extension to cofactor networks: The same platform can be expanded to include NAD species, vitamins, one-carbon or CoA-related metabolites when you need broader pathway coverage.

Analytical Platform for Nicotinate and Nicotinamide Analysis

Core Instruments

Our nicotinate and nicotinamide panel is run on targeted LC–MS/MS platforms commonly used in small-molecule metabolomics.

UHPLC systems: High-performance UHPLC with binary pumps and autosamplers for low-volume injections and stable gradients.

Triple quadrupole mass spectrometers (primary quantification)

Representative platforms used in targeted metabolomics, such as:

  • Thermo Scientific TSQ series triple quadrupole systems.
  • AB Sciex QTRAP or API series triple quadrupole instruments.

These are operated in electrospray ionization (ESI), typically in positive mode, using MRM for nicotinate, nicotinamide, and related metabolites.

High-resolution MS (method development and confirmation, when needed)

Orbitrap or TOF-based instruments (for example Thermo Q Exactive or similar HRMS systems) can be used to confirm identities and refine transitions before locking the routine LC–MS/MS method.

Method Performance Parameters

Parameter Typical setup for nicotinate/nicotinamide panel
Chromatography mode UHPLC, reversed-phase or mixed-mode gradient
Column Short analytical column for polar pyridine metabolites
Mobile phases Aqueous buffer with volatile acid or salt; organic phase methanol or acetonitrile
Flow rate Sub-mL/min range to balance resolution, sensitivity, and throughput
Injection volume Low-µL range to maintain peak shape and reproducibility
Ionization Electrospray ionization (ESI), positive mode
Acquisition mode Triple quadrupole MRM with optimized precursor/product ion pairs
Linearity target Calibration curves tuned for strong linearity (R² typically ≥ 0.99)
Internal standards Isotope-labeled standards for nicotinamide/nicotinate where available
Batch quality control Regular pooled QC and calibration checks to monitor drift and stability
SCIEX Triple Quad™ 6500+

Triple Quad™ 6500+ (Figure from Sciex)

Thermo Scientific TSQ Altis Triple Quadrupole MS

TSQ Altis Triple Quadrupole MS (Figure from Thermo Scientific)

Thermo Fisher Q Exactive

Thermo Fisher Q Exactive (Figure from Thermo Fisher)

Agilent 1260 Infinity II HPLC

Agilent 1260 Infinity II HPLC (Fig from Agilent)

From Sample to Data: Nicotinate and Nicotinamide Analysis Workflow

1

Project consultation and panel design

Clarify your research questions, sample types, target analytes, and any co-panels (for example NAD, one-carbon metabolites).

2

Sample receipt and pre-analytical QC

Verify sample identity, volume or mass, container type, storage conditions, and freeze–thaw history; document any deviations.

3

Metabolite extraction and preparation

Perform protein precipitation and extraction under cold conditions, add internal standards, and, where needed, adjust pH or use stabilizing additives to protect labile metabolites.

4

LC–MS/MS acquisition

Separate pyridine metabolites under reversed-phase or mixed-mode chromatography and detect them by MRM in positive ion mode.

5

Data processing and quality control

Integrate peaks, review retention times, check calibration curves and QC samples, and flag any outliers or issues.

6

Quantitative reporting and optional interpretation

Generate concentration tables, ratios, and basic visualizations, and—if requested—summarize key findings in the context of nicotinate/nicotinamide and NAD pathway biology.

Nicotinate and Nicotinamide Analysis Service Workflow

Sample Requirements for Nicotinate and Nicotinamide LC–MS/MS Analysis

Sample type Recommended amount Container Storage & transport notes
Blood / plasma / serum ≥ 500 µL per sample Pre-labeled cryovial, anticoagulant as appropriate Keep frozen; ship on dry ice; avoid repeated freeze–thaw cycles.
Urine ≥ 1 mL per sample Screw-cap tube or cryovial Mix well before aliquoting; freeze promptly; send on dry ice.
Solid tissue ~ 200 mg per sample Pre-cooled tube Snap-freeze after collection; keep at ultra-low temperature; ship on dry ice.
Cultured cells ≥ 1 × 10⁷ cells per sample Tube compatible with rapid quenching Quench metabolism rapidly; store pellets frozen; transport on dry ice.
Feces or digesta ~ 500 mg per sample Leak-proof tube Freeze as soon as possible; ship on dry ice to preserve metabolite stability.

For other matrices such as culture media, formulated products, or specialized biological fluids, tailored requirements can be defined during project setup.

What You Receive: Nicotinate and Nicotinamide Analysis Deliverables

Method & run summary: PDF with sample list and groups, run order, and a short method description (prep outline, LC gradient, MS mode, key MRM transitions).

Raw LC–MS/MS files: Vendor-format raw data for standards, QCs, and all study samples.

Processed result tables: Editable spreadsheets (e.g., .xlsx) with peak areas and calculated concentrations for each analyte, linked to sample IDs.

Calibration & QC report: Brief report summarizing calibration curves, QC performance, and any excluded injections or notes.

Optional figures: Simple charts (bar/box plots, group comparisons) for key nicotinate/nicotinamide levels and ratios, if requested.

Four LC–MS/MS MRM panels for nicotinate, nicotinamide, NAD⁺, and NMN comparing blank, QC, and experimental traces with sharp peaks.

Representative LC–MS/MS MRM chromatograms of nicotinate, nicotinamide, NAD⁺, and NMN in blank, QC, and experimental samples, showing specific and well-resolved peaks.

LC–MS/MS calibration plot for NAD⁺ with seven points, a linear fit with high R², and dashed LLOQ and ULOQ limits.

NAD⁺ LC–MS/MS calibration curve with seven standards, linear regression and R², and LLOQ/ULOQ markers defining the quantitative range.

Research Applications of Nicotinate and Nicotinamide Profiling

Redox and energy metabolism research

Track NAD precursor pools under metabolic stress or nutrient perturbation.

Drug mechanism and target engagement

Evaluate how small molecules influence nicotinate/nicotinamide utilization and salvage pathways.

Mitochondrial and oxidative stress studies

Relate precursor availability to changes in mitochondrial function and reactive oxygen species handling.

Nutrition and functional ingredient evaluation

Characterize how diets, supplements, or fortification strategies affect vitamin B3–related metabolites.

One-carbon and cofactor network mapping

Integrate nicotinate/nicotinamide data with folate, SAM/SAH, and other cofactor pathways.

Microbiome–host interaction research

Explore how microbial metabolism shapes host pyridine metabolites such as trigonelline or nicotinurate.

What is the difference between nicotinate and nicotinamide analysis and general NAD⁺ metabolomics?

General NAD⁺ metabolomics often provides a broad snapshot of NAD⁺, NADH, NADP⁺, and NADPH. Nicotinate and nicotinamide analysis adds specific focus on vitamin B3 precursors and their degradation products. This helps you understand not only cofactor levels but also how efficiently the system synthesizes, recycles, and clears these metabolites.

Can you work with archived or biobank samples?

Usually yes, as long as samples have been kept frozen and not cycled repeatedly between freeze and thaw. We often suggest a small pilot run on a subset to check background, signal stability, and obvious degradation before you commit the full cohort.

How many samples do I need for a meaningful study?

Statistical power depends more on a clear design than on a specific number. We recommend well-defined groups with biological replicates, appropriate controls, and—where possible—randomized run order so that technical variation does not confound group differences.

Do you provide absolute or relative quantification?

Core analytes such as nicotinate, nicotinamide, and key NAD intermediates are measured against external calibration with authentic standards and isotope-labeled internal standards, so you receive absolute concentrations. Certain peripheral metabolites may be reported as normalized response ratios when suitable standards are not available or not requested.

Can you handle unusual or complex matrices?

For matrices such as formulated products, perfusates, or specialized biofluids, we typically adapt extraction, dilution, and clean-up to control ion suppression. Matrix-matched calibration or spike-recovery experiments can be added to confirm that nicotinate and nicotinamide behave quantitatively in your specific matrix.

How are multi-batch or multi-phase projects kept comparable?

We use shared calibration strategies, bridging QC samples, and stable internal standards across batches. Longitudinal QC review allows us to detect shifts early and apply appropriate normalization so that data from different phases can still be interpreted as a single study.

Resting natural killer cell homeostasis relies on tryptophan/NAD+ metabolism and HIF-1α

Pelletier, A., Nelius, E., Fan, Z., Khatchatourova, E., Alvarado-Diaz, A., He, J., ... & Stockmann, C.

Journal: EMBO Reports

Year: 2023

Enhance Trial: Effects of NAD3® on Hallmarks of Aging and Clinical Endpoints of Health in Middle Aged Adults: A Subset Analysis Focused on Blood Cell NAD+ Concentrations and Lipid Metabolism

Roberts, M. D., Osburn, S. C., Godwin, J. S., Ruple, B. A., La Monica, M. B., Raub, B., ... & Lopez, H. L.

Journal: Physiologia

Year: 2022

Inflammation primes the kidney for recovery by activating AZIN1 A-to-I editing

Heruye, S., Myslinski, J., Zeng, C., Zollman, A., Makino, S., Nanamatsu, A., ... & Hato, T.

Journal: bioRxiv

Year: 2023

Insulin resistance does not impair mechanical overload-stimulated glucose uptake, but does alter the metabolic fate of glucose in mouse muscle

Weyrauch, L. A., McMillin, S. L., & Witczak, C. A.

Journal: International Journal of Molecular Sciences

Year: 2020

Sarcosine Is Uniquely Modulated by Aging and Dietary Restriction in Rodents and Humans

Walters, R. O., Arias, E., Diaz, A., Burgos, E. S., Guan, F., Tiano, S., ... & Huffman, D. M.

Journal: Cell Reports

Year: 2018

For Research Use Only. Not for use in diagnostic procedures.
inquiry

Get Your Custom Quote

Connect with Creative Proteomics Contact UsContact Us
return-top